Product Images Levonorgestrel And Ethinyl Estradiol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Levonorgestrel And Ethinyl Estradiol NDC 68462-672 by Glenmark Pharmaceuticals Inc., Usa, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

carton

carton

NDC 68462-672-95 is a prescription product manufactured by Glenmark Pharmaceuticals Ltd in Goa, India. It is an extended-cycle tablet dispenser containing Levonorgestrel and Ethinyl Estradiol Tablets, USP in the strength of 15 mg/0.03 mg with a pack of 3 pouches, each containing 91 tablets. The usual dosage of this oral contraceptive is one tablet daily for 91 consecutive days in the following order: 84 blue tablets followed by 7 white inert tablets as prescribed. This product is intended to prevent pregnancy but does not protect against HIV infection (AIDS) and other sexually transmitted diseases. Store the medication at 20° to 25°C (68° to 77°F); excursions permitted 10 15° to 30°C (59° to 86°F) and protect from light.*

Chart - chart

Chart - chart

This text describes different methods of birth control and their effectiveness rates, represented by the number of pregnancies per 100 women in one year. The text suggests that implants, injections, intrauterine devices, and sterilization are the most effective methods, with fewer than 1 pregnancy per 100 women in one year. Birth control pills, a skin patch, and a vaginal ring with hormones are also mentioned but with lower effectiveness rates. Additionally, condoms, diaphragms, spermicide, withdrawal, and avoiding sex during the most fertile days of the monthly cycle are mentioned but with higher effectiveness rates. Finally, the absence of birth control is also mentioned.*

eestructure

eestructure

figure a

figure a

figure b

figure b

figure c

figure c

This text provides a list of relevant studies examining the risk of breast cancer with the use of combined oral contraceptives. It includes the names of the studies, their authors, and their publication dates. The studies compare the risk of breast cancer in women who have used combined oral contraceptives versus those who have never used them. The text also includes an "Effect Estimate" chart, which is not readable.*

figurea

figurea

figureb

figureb

Levonorgestrel and Ethinyl Estradiol Tablets is a medication classified under oral contraceptives. The text includes some unreadable characters that may contain relevant information.*

figurec

figurec

This text appears to be a label for Levonorgestrel and Ethinyl Estradiol Tablets, USP, which are used for contraception. The label includes the brand name "EE-Texil" and some technical information such as dosages and product codes.*

levonorgestrel

levonorgestrel

logo

logo

logo1

logo1

logo2

logo2

pouch

pouch

This is a package insert for a medication called Levonorgestrel and Ethinyl Estradiol Tablets. The medication is intended for preventing pregnancy and does not protect against HIV or other sexually transmitted diseases. The package contains 91 tablets, 84 blue tablets containing 0.15 mg levonorgestrel USP and 0.03 mg cthinyl estradiol USP and 7 white inert tablets. The dosage is one tablet daily for 91 consecutive days. The medication should be stored at controlled room temperature and kept out of reach of children. It is manufactured by Glenmark Pharmaceuticals Inc., USA.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.